Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

Similar articles for PubMed (Select 22898981)

1.

Renal complications of Fabry disease in children.

Najafian B, Mauer M, Hopkin RJ, Svarstad E.

Pediatr Nephrol. 2013 May;28(5):679-87. doi: 10.1007/s00467-012-2222-9. Epub 2012 Aug 17. Review.

2.

Anderson-Fabry disease: a multiorgan disease.

Tuttolomondo A, Pecoraro R, Simonetta I, Miceli S, Pinto A, Licata G.

Curr Pharm Des. 2013;19(33):5974-96. Review.

PMID:
23448451
3.

Assessment of renal pathology and dysfunction in children with Fabry disease.

Ramaswami U, Najafian B, Schieppati A, Mauer M, Bichet DG.

Clin J Am Soc Nephrol. 2010 Feb;5(2):365-70. doi: 10.2215/CJN.08091109. Epub 2010 Jan 7. Review.

4.

Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy?

Waldek S, Feriozzi S.

BMC Nephrol. 2014 May 6;15:72. doi: 10.1186/1471-2369-15-72. Review.

5.

Enzyme replacement therapy and Fabry nephropathy.

Warnock DG, Daina E, Remuzzi G, West M.

Clin J Am Soc Nephrol. 2010 Feb;5(2):371-8. doi: 10.2215/CJN.06900909. Epub 2009 Dec 10.

6.

Fabry disease.

Germain DP.

Orphanet J Rare Dis. 2010 Nov 22;5:30. doi: 10.1186/1750-1172-5-30. Review.

7.

Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease.

Prabakaran T, Birn H, Bibby BM, Regeniter A, Sørensen SS, Feldt-Rasmussen U, Nielsen R, Christensen EI.

Nephrol Dial Transplant. 2014 Mar;29(3):619-25. doi: 10.1093/ndt/gft452. Epub 2013 Nov 8.

PMID:
24215016
8.

What lies beneath: Fabry nephropathy in a female patient with severe cerebrovascular disease.

Romão EA, Lourenço CM, Júnior WM, Rolfs A, Muñoz V, Vieira Neto OM, Dantas M, Silva GE, Costa RS.

Clin Nephrol. 2013 Apr;79(4):330-4.

PMID:
23537685
9.

Renal complications of Fabry disease.

Basic-Jukic N, Kes P, Coric M, Basic-Kes V.

Curr Pharm Des. 2013;19(33):6046-50. Review.

PMID:
23448456
10.

Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapy.

Mignani R, Feriozzi S, Schaefer RM, Breunig F, Oliveira JP, Ruggenenti P, Sunder-Plassmann G.

Clin J Am Soc Nephrol. 2010 Feb;5(2):379-85. doi: 10.2215/CJN.05570809. Epub 2010 Jan 7. Review.

11.

Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations.

Oqvist B, Brenner BM, Oliveira JP, Ortiz A, Schaefer R, Svarstad E, Wanner C, Zhang K, Warnock DG.

Nephrol Dial Transplant. 2009 Jun;24(6):1736-43. doi: 10.1093/ndt/gfp105. Epub 2009 Mar 16. Review. No abstract available.

12.

The kidney in Fabry's disease.

Pisani A, Visciano B, Imbriaco M, Di Nuzzi A, Mancini A, Marchetiello C, Riccio E.

Clin Genet. 2014 Oct;86(4):301-9. doi: 10.1111/cge.12386. Epub 2014 May 30.

PMID:
24645664
13.

Enzyme replacement therapy for Fabry disease, an inherited nephropathy.

Desnick RJ, Banikazemi M, Wasserstein M.

Clin Nephrol. 2002 Jan;57(1):1-8. Review.

PMID:
11837797
14.

Progressive renal failure despite long-term biweekly enzyme replacement therapy in a patient with Fabry disease secondary to a new α-galactosidase mutation of Leu311Arg (L311R).

Suzuki K, Miura N, Kitagawa W, Suzuki S, Komatsuda A, Nishikawa K, Watanabe D, Imai H.

Clin Exp Nephrol. 2011 Dec;15(6):916-20. doi: 10.1007/s10157-011-0486-1. Epub 2011 Jul 15. Review.

PMID:
21755431
15.
16.

[Fabry nephropathy in a female with superposed IgA glomerulonephritis].

Pisani A, Sessa A, Sabbatini M, Andreucci MV, Fusco C, Balletta M, Cianciaruso B.

G Ital Nefrol. 2005 Jul-Aug;22(4):385-9. Italian.

PMID:
16267800
17.

Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults.

Ortiz A, Oliveira JP, Wanner C, Brenner BM, Waldek S, Warnock DG.

Nat Clin Pract Nephrol. 2008 Jun;4(6):327-36. doi: 10.1038/ncpneph0806. Epub 2008 Apr 22.

PMID:
18431378
18.

Renal pathological changes in Fabry disease.

Sessa A, Meroni M, Battini G, Maglio A, Brambilla PL, Bertella M, Nebuloni M, Pallotti F, Giordano F, Bertagnolio B, Tosoni A.

J Inherit Metab Dis. 2001;24 Suppl 2:66-70; discussion 65. Review.

PMID:
11758681
19.

Renal manifestations in Fabry disease and therapeutic options.

Torra R.

Kidney Int Suppl. 2008 Dec;(111):S29-32. doi: 10.1038/ki.2008.522. Review.

20.

Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN).

Fogo AB, Bostad L, Svarstad E, Cook WJ, Moll S, Barbey F, Geldenhuys L, West M, Ferluga D, Vujkovac B, Howie AJ, Burns A, Reeve R, Waldek S, Noël LH, Grünfeld JP, Valbuena C, Oliveira JP, Müller J, Breunig F, Zhang X, Warnock DG; all members of the International Study Group of Fabry Nephropathy (ISGFN).

Nephrol Dial Transplant. 2010 Jul;25(7):2168-77. doi: 10.1093/ndt/gfp528. Epub 2009 Oct 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk